TY  - RPRT
TI  - Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
AU  - Takazawa, S.
AU  - Kotaki, T.
AU  - Nakamura, S.
AU  - Utsubo, C.
AU  - Kameoka, M.
PY  - 2023
DO  - 10.1101/2023.02.15.528742
UR  - https://www.biorxiv.org/content/10.1101/2023.02.15.528742v1
ID  - 10.1101/2023.02.15.528742
ER  -